The Office of the Attorney-General (OAG) has finished reviewing the Government Pharmaceutical Organization's (GPO) draft supply agreement for the purchase of the US-made Moderna Covid-19 vaccine.
The office returned the document to the GPO for further action yesterday morning, OAG Deputy Spokesman Prayuth Phetkhun said in a statement. Mr Prayuth said the OAG had received the draft from the GPO for review on Friday at 2pm.
Attorney-general Wongsakul Kittipromwong said the OAG, aware that time was of the essence, had assigned Naree Tanthasathien, director-general of the Department of Legal Counsel, to work on it over the weekend.
The department finished the examination of the draft at 10pm on Sunday and it was returned to the GPO for further proceedings on Monday morning, Mr Prayuth said.
He said the OAG had also examined a number of draft contracts to buy vaccines against Covid-19.
The office spent one day examining the draft for the purchase of Sinovac vaccines and five days on the same document for AstraZeneca vaccines.
As for the draft contract to buy the Pfizer-BioNTech vaccine, the OAG received it from the Department of Disease Control on June 29. After finishing the review, it was also returned to the department on Monday morning.
There are no more vaccine contracts currently under review at the office, and the OAG said it has yet to receive similar drafts for other brands such as for Sputnik V and Johnson & Johnson, Mr Prayuth added.
Meanwhile, Jetsadanee Iamsupatsawat, communications manager at Pfizer Thailand, said yesterday the Food and Drug Administration had granted emergency use authority for the Pfizer-BioNTech Covid-19 vaccine on June 24.